Notice: Trying to get property of non-object in /srv/www/html/sustainabledevelopment.un.org/root/content.php on line 225
Merck commits an estimated $840 million over the next 5 years through their HIV prevention and treatment, childhood asthma programs and donation of HPV vaccine .:. Sustainable Development Knowledge Platform
Information
  • Submitted by: Merck
  • Topic: Health and population
  • Keywords: Financial Mechanism; AIDS; Children and Women's Health; Youth; Population and Development
  • Location: Low-income Countries
  • Date of completion: 2015
  • Click for more information
Deliverables & Resources
Action network
  • This voluntary initiative came from Every Woman Every Child
Merck commits an estimated $840 million over the next 5 years through their HIV prevention and treatment, childhood asthma programs and donation of HPV vaccine

Partner(s)

Qiagen

Description/achievement of initiative

2010: Merck commits an estimated $840 million over the next 5 years through their HIV prevention and treatment, childhood asthma programs and donation of HPV vaccine, GARDASIL®, to organizations and institutions in eligible lowest income countries to enable countries to develop capacity to implement vaccination programs. Merck and Qiagen are also committed to increasing access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world through up to five million doses of GARDASIL and HPV DNA tests to screen an additional 500,000 women. The two companies will also support the development and implementation of sustainable best practice models for cervical cancer reduction in low-income, high disease burden countries.

Implementation methodologies

Through Merck's HIV prevention and treatment, childhood asthma programs and donation of HPV vaccine, GARDASIL®, to organizations and institutions in eligible lowest income countries to enable countries to develop capacity to implement vaccination programs. Merck will also partner with Qiagen in increasing access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world.

Deliverables
Deliverable Date
Merck commits an estimated $840 million over the next 5 years through their HIV prevention and treatment, childhood asthma programs and donation of HPV vaccine, GARDASIL®, to organizations and institutions in eligible lowest income countries to enable countries to develop capacity to implement vaccination programs. 2015
Resources
Type Details
Financing (in USD) $840,000,000
In-kind contribution Increasing access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world through up to five million doses of GARDASIL and HPV DNA tests to screen an additional 500,000 women.
Copyright United Nations Department of Economic and Social Affairs, Division for Sustainable Development | Contact | Terms of use | Site map

Notice: Trying to get property of non-object in /srv/www/html/sustainabledevelopment.un.org/root/content.php on line 553